Clincosm LogoSign in Get a demo

Multiple Myeloma

Showing NaN - NaN of 228
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin frozen liquid, Belantamab mafodotin lyophilized powder)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Belantamab mafodotin frozen liquid
  • Belantamab mafodotin lyophilized powder
  • New Haven, Connecticut
  • +58 more
Jul 27, 2022

Multiple Myeloma Trial in Worldwide (bb2121)

Active, not recruiting
  • Multiple Myeloma
  • bb2121
  • San Francisco, California
  • +47 more
Jul 18, 2022

Multiple Myeloma Trial in Canada, United States (PF-06863135 monotherapy IV or SC, PF-06863135 + dexamethasone, PF-06863135 +

Active, not recruiting
  • Multiple Myeloma
  • PF-06863135 monotherapy IV or SC
  • +3 more
  • Encinitas, California
  • +37 more
Jul 7, 2022

Multiple Myeloma Trial in Boston, Milwaukee (CART-ddBCMA)

Not yet recruiting
  • Multiple Myeloma
  • CART-ddBCMA
  • Boston, Massachusetts
  • +1 more
Jul 7, 2022

Multiple Myeloma Trial in United States (bb2121, Fludarabine, Cyclophosphamide)

Active, not recruiting
  • Multiple Myeloma
  • bb2121
  • +3 more
  • Scottsdale, Arizona
  • +19 more
Jul 7, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Pomalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • +3 more
  • Tucson, Arizona
  • +131 more
Jul 1, 2022

Multiple Myeloma Trial in Worldwide (Daratumumab, Durvalumab, Pomalidomide)

Completed
  • Multiple Myeloma
  • Duarte, California
  • +43 more
Jun 9, 2022

Lymphoma, Multiple Myeloma Trial in Worldwide (Lenalidomide, Dexamethasone, Dexamethasone (Oral))

Completed
Has Results
  • Lymphoma
  • Multiple Myeloma
  • Muscle Shoals, Alabama
  • +215 more
May 5, 2022

Multiple Myeloma, Multiple Myeloma in Relapse Trial in Boston (Ixazomib, Pomalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Multiple Myeloma in Relapse
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Apr 13, 2022

Developing Myeloma in a High-Risk Screened Population (PROMISE)

Recruiting
  • Multiple Myeloma
  • Sample of Blood
  • Baltimore, Maryland
  • +2 more
Mar 22, 2022

Multiple Myeloma Trial in United States (Elotuzumab in combination with Lenalidomide and Dexamethasone)

No longer available
  • Multiple Myeloma
  • Elotuzumab in combination with Lenalidomide and Dexamethasone
  • Concord, California
  • +26 more
Mar 17, 2022

Questionnaire and Tissue Banking For Multiple Myeloma,

Active, not recruiting
  • Multiple Myeloma
  • +3 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Mar 15, 2022

    Multiple Myeloma Trial in Worldwide (Dexamethasone, Daratumumab, Venetoclax)

    Active, not recruiting
    • Multiple Myeloma
    • Aurora, Colorado
    • +39 more
    Mar 2, 2022

    Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma Trial in United States (CYT-0851, CYT-0851 in combination with gemcitabine,

    Recruiting
    • Malignancy
    • +14 more
    • Scottsdale, Arizona
    • +17 more
    Mar 7, 2022

    Multiple Myeloma Trial in Worldwide (Melphalan flufenamide (Melflufen), Dexamethasone, Bortezomib)

    Terminated
    • Multiple Myeloma
    • Melphalan flufenamide (Melflufen)
    • +3 more
    • Boston, Massachusetts
    • +15 more
    Mar 4, 2022

    Multiple Myeloma Trial in United States (ACY-1215, lenalidomide, Dexamethasone)

    Completed
    • Multiple Myeloma
    • Boston, Massachusetts
    • +4 more
    Feb 7, 2022

    Multiple Myeloma Trial in United States (Bortezomib, Lenalidomide, Dexamethasone)

    Active, not recruiting
    • Multiple Myeloma
    • Denver, Colorado
    • +7 more
    Feb 11, 2022

    Multiple Myeloma Trial in Worldwide (Melphalan flufenamide (Melflufen), Dexamethasone)

    Completed
    Has Results
    • Multiple Myeloma
    • Whittier, California
    • +19 more
    Feb 2, 2022

    Multiple Myeloma Trial in Worldwide (Elotuzumab, Dexamethasone, Lenalidomide)

    Active, not recruiting
    • Multiple Myeloma
    • Tucson, Arizona
    • +37 more
    Jan 14, 2022

    Multiple Myeloma Trial in Worldwide (Elotuzumab, Pomalidomide, Dexamethasone)

    Completed
    Has Results
    • Multiple Myeloma
    • Atlanta, Georgia
    • +54 more
    Jan 11, 2022

    Multiple Myeloma Trial in Boston (CIML NK Cells plus KP1237 and low dose IL-2)

    Recruiting
    • Multiple Myeloma
    • CIML NK Cells plus KP1237 and low dose IL-2
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jan 18, 2022

    Multiple Myeloma Trial in Duarte, Boston, Portland (SL-401/ Pomalidomide/ Dexamethasone)

    Terminated
    • Multiple Myeloma
    • SL-401/ Pomalidomide/ Dexamethasone
    • Duarte, California
    • +2 more
    Jan 13, 2022

    Multiple Myeloma, Lymphoma, Amyloidosis Trial in Worldwide (Ixazomib)

    Active, not recruiting
    • Multiple Myeloma
    • +2 more
    • Atlanta, Georgia
    • +23 more
    Dec 20, 2021

    Multiple Myeloma Trial in United States (Lenalidomide, Elotuzumab, Bortezomib)

    Active, not recruiting
    • Multiple Myeloma
    • Atlanta, Georgia
    • +6 more
    Dec 17, 2021

    Multiple Myeloma Trial in United States (Lenalidomide, lenalidomide, bortezomib and dexamethasone)

    Completed
    Has Results
    • Multiple Myeloma
    • Tucson, Arizona
    • +53 more
    Dec 8, 2021